chronic cough

News

Kyorin partners Hyfe to develop DTx for chronic cough

Kyorin Pharma has signed a deal with Hyfe to develop a digital therapeutic (DTx) for people with chronic cough and launch it in Japan.

Patients

pharmaphorum podcast Episode 147a featuring Farrell Simon

Chronic cough and the patient voice

Chronic cough impacts up to 10% of the adult population and has a physical, psychological, and social impact on patients’ lives.

News

Andexxa reaches the end of the line in the US

AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US amid reports of serious clotting side effects.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks